Oxycodone,Dosges,Consumer Information,Side Effects,Drug Interaction,Medicines Exporters,Distributors,Precaution,Causes,Consumer Information,Causes,Importer,Drug Exporters in India, Other,Causes,Uses,Raw Material Suppliers,Injection Manufacaturer,Fda Approval,Taj Pharmaceuticals Ltd.

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Oxycodone taj Pharmaceuticals API

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Oxycodone Manufacturers in India Suppliers Oxycodone Dossage Exporters Distributors Oxycodone api active pharmaceuticals ingredients Oxycodone manufacturers Side Effects bulk drugs raw material Dossage Oxycodone companies Side Effects Dossage Importers Oxycodone Dossage Oxycodone Exporters Oxycodone exporters Dossage FDA Dossage Oxycodone Dossage DMF Symptoms Dossage Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Oxycodone manufacturing pharmaceutical drugs pharmaceutical intermediates Oxycodone pharmaceutical chemicals pharmaceutical raw materials Oxycodone active pharmaceutical ingredients Oxycodone committee active pharmaceutical ingredients manufacturer Oxycodone Active Pharmaceutical Ingredients manufacturer Oxycodone exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Oxycodone, Oxycodone manufacturer India, Oxycodone product, Oxycodone products, Api preparation, Certificate of Analysis API manufacturer product, Oxycodone anti ulcer product, Certificate of Origin COA Oxycodone COS Oxycodone, pharmaceutical generic, pharmaceutical drug, medical, Oxycodone pharma healthcare, pharma patents, contract MSDS manufacturing Trader Oxycodone pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Oxycodone expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Oxycodone DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Oxycodone ingredients, api, HIV Oxycodone, tablets, capsules, syrup & protein Oxycodone powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Oxycodone gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Oxycodone WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API >>>
	Pharmaceuticals API List
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

Oxycodone taj API Img.

HOME >> API >> API List 4 >> Oxycodone >> Dosage

DOSAGE
Oxycodone CAS number 76-42-6

The usual starting dose using immediate release oxycodone tablets is 10 to 30 mg every 4 hours. Patients who have never received opioids should receive 5-15 mg every 4 to 6 hours. Some patients may require 30 mg or more every 4 hours.

The starting dose using immediate release capsules is 5 mg every 6 hours.

Continuous release tablets are administered every 12 hours and are used when around the clock treatment is required for an extended time period. Continuous release tablets should not be broken, crushed or chewed; swallow tablets whole. Broken, crushed or chewed continuous release tablets may lead to increased absorption and dangerous levels of oxycodone.

The 80 mg and 160 mg tablets should only be used by patients who require daily doses of at least 160-320 mg and are tolerant to opioid therapy. Administration of large doses to opioid-naïve patients may lead to profound depression of breathing.

The usual adult dose of oral concentrate solution (20 mg/ml) is 5 mg every 6 hours.

The usual adult dose for the oral solution (5 mg/ml) is 10-30 mg every 4 hours.

Information Associated with Product:

DRUG DESCRIPTION

DOSAGE >>

SIDE EFFECTS

PRECAUTIONS

INTERACTION

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj Pharmaceuticals API Logo

Api Manufacturer,Export,Supplies,Manufacturing in India

Acenocoumarol	Aluminium-magnesium	Buprenorphine HCl	Dihydrocodeine hydrogentartrate	Ethylmorphine HCl	Glibornuride	Hydroxychloroquine sulphate	Noroxymorphone	Noscapine base
Oxycodone	Oxymorphone	Phenobarbital acid	Phenobarbital sodium	Thebaine

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.